0001104659-24-104940.txt : 20241001 0001104659-24-104940.hdr.sgml : 20241001 20241001161908 ACCESSION NUMBER: 0001104659-24-104940 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241001 FILED AS OF DATE: 20241001 DATE AS OF CHANGE: 20241001 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Centogene N.V. CENTRAL INDEX KEY: 0001757097 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39124 FILM NUMBER: 241343542 BUSINESS ADDRESS: STREET 1: AM STRANDE 7 CITY: ROSTOCK STATE: 2M ZIP: 18055 BUSINESS PHONE: 49 30 2130 00325 MAIL ADDRESS: STREET 1: AM STRANDE 7 CITY: ROSTOCK STATE: 2M ZIP: 18055 FORMER COMPANY: FORMER CONFORMED NAME: Centogene B.V. DATE OF NAME CHANGE: 20181025 6-K 1 tm2425366d1_6k.htm FORM 6-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2024

Commission File Number 001-39124

Centogene N.V.
(Translation of registrant's name into English)

Am Strande 7
18055 Rostock

Germany
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

Centogene N.V.

Supervisory Board Matters

Centogene N.V. (the “Company”) previously announced the resignation of Peer Schatz, Mary Sheahan and Jonathan Sheldon from the Supervisory Board of the Company (the “Supervisory Board”) effective as of September 30, 2024. Mr. Schatz and Ms. Sheahan have since each notified the Company that they will defer the effective date of their respective resignations from the Supervisory Board to October 15, 2024. The Supervisory Board has approved each such deferral.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: October 1, 2024

	CENTOGENE N.V.

	By:	/s/ Peter Bauer
		Name:	Peter Bauer
		Title:	Chief Medical & Genomic Officer